Literature DB >> 28677834

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.

Mythri Mudireddy1, Sahrish Shah1, Terra Lasho1, Daniela Barraco1, Curtis A Hanson2, Rhett P Ketterling2, Naseema Gangat1, Animesh Pardanani1, Ayalew Tefferi1.   

Abstract

Entities:  

Keywords:  distinction; prefibrotic PMF; primary myelofibrosis; prognosis; reticulin fibrosis

Mesh：

Year:  2017        PMID： 28677834     DOI： 10.1111/bjh.14838

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  SOHO State-of-the-Art Update and Next Questions: MPN.

Authors:  Prithviraj Bose; Jason Gotlib; Claire N Harrison; Srdan Verstovsek
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-01

2.  Targeted next-generation sequencing in blast phase myeloproliferative neoplasms.

Authors:  Terra L Lasho; Mythri Mudireddy; Christy M Finke; Curtis A Hanson; Rhett P Ketterling; Natasha Szuber; Kebede H Begna; Mrinal M Patnaik; Naseema Gangat; Animesh Pardanani; Ayalew Tefferi
Journal:  Blood Adv       Date:  2018-02-27

3.  Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.

Authors:  Sebastiano Rontauroli; Sara Castellano; Paola Guglielmelli; Roberta Zini; Elisa Bianchi; Elena Genovese; Chiara Carretta; Sandra Parenti; Sebastian Fantini; Selene Mallia; Lara Tavernari; Stefano Sartini; Margherita Mirabile; Carmela Mannarelli; Francesca Gesullo; Annalisa Pacilli; Daniela Pietra; Elisa Rumi; Silvia Salmoiraghi; Barbara Mora; Laura Villani; Andrea Grilli; Vittorio Rosti; Giovanni Barosi; Francesco Passamonti; Alessandro Rambaldi; Luca Malcovati; Mario Cazzola; Silvio Bicciato; Enrico Tagliafico; Alessandro M Vannucchi; Rossella Manfredini
Journal:  Blood Adv       Date:  2021-03-09

4.  Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study.

Authors:  Lan Zhang; Xingnong Ye; Shuna Luo; Xiaofei Xu; Shengjie Wang; Keyi Jin; Yan Zheng; Xiaoqiong Zhu; Dan Chen; Jie Jin; Jian Huang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-22       Impact factor: 4.553

5.  Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosis.

Authors:  Chi-Keung Cheng; Jennifer W Y Lai; Yuk-Lin Yung; Hoi-Yun Chan; Raymond S M Wong; Natalie P H Chan; Joyce S Cheung; Xi Luo; Herbert-Augustus Pitts; Margaret H L Ng
Journal:  EJHaem       Date:  2021-12-30

Review 6.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037

Review 7.  Prefibrotic myelofibrosis: treatment algorithm 2018.

Authors:  Guido Finazzi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

Review 8.  Myelofibrosis Treatment Algorithm 2018.

Authors:  Ayalew Tefferi; Paola Guglielmelli; Animesh Pardanani; Alessandro M Vannucchi
Journal:  Blood Cancer J       Date:  2018-07-31       Impact factor: 11.037

9.  Ruxolitinib for the Treatment of Essential Thrombocythemia.

Authors:  Arief Gunawan; Patrick Harrington; Natalia Garcia-Curto; Donal McLornan; Deepti Radia; Claire Harrison
Journal:  Hemasphere       Date:  2018-06-12

10.  Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates.

Authors:  Sahrish Shah; Mythri Mudireddy; Curtis A Hanson; Rhett P Ketterling; Naseema Gangat; Animesh Pardanani; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2017-12-18       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.